Skip Navigation Links


 I.      Introduction: We are pleased to offer you in this website the following prediction tools for predicting the clinical outcome of an individual patient with localized or regional cutaneous melanoma. The prediction tools can be used to predict the 1, 2, 5 and 10-year survival rates from initial diagnosis (with a 95% confidence interval) for an individual patient based on his/her relevant clinical and pathologic information. The predictive models were developed and validated using a combined database (n=28,047) from 11 major institutions and study groups participating in the development of the 7th edition of the American Joint Committee on Cancer (AJCC) Melanoma Staging System. This database includes 25,734 patients with localized melanoma and 2,313 patients with regional melanoma with relevant information available for model development. For detailed results regarding our prognostic factor analyses, model development and validation, please see the relevant manuscripts listed in the References section. Several additional useful prediction tools currently under development will be added to this website in the near future. References  | Acknowledgements

In November of 2010, an enhancement of the website was done to include an estimated hazard function for an individual patient in the prediction tools.

If you are interested in using the prediction tools on this website, please read carefully the following disclaimer.


  II.    Terms of Use: The melanoma prediction tools located on this website are for general health information only. The clinical outcome prediction information should not be used as a substitute for medical advice, diagnosis or treatment of any health condition or problem. These prediction tools are presented as research in progress, as they will continue to be refined. Users of the prediction tools should not rely on information provided by the prediction tools for their own health problems. Questions should be addressed to your own physician or other health care provider. The University of Alabama at Birminghamm, the American Joint Committee on Cancer, the American College of Surgeons, the Sydney Melanoma Unit, as well as those additional institutions that contributed their data to the database for developing these tools, make no warranties, or expressed or implied representations whatsoever regarding the accuracy, completeness, timeliness, comparative, or controversial nature, or usefulness of any information contained or referenced in the prediction tools. These institutions do not assume any risk whatsoever for use of the prediction tools or the information contained herein. Use of the prediction tools does not create an expressed or implied physician-patient relationship. These institutions also do not endorse or claim validity for the prediction tools found on this website. These melanoma prediction tools do not record specific prediction tool user information, and do not contact users of the prediction tools. You are advised to consult with a physician or other professional health care provider prior to making any decisions or not undertaking any actions related to any health care problem or issue you might have at any time, now or in the future. By using the prediction tools, you agree that none of the referenced institutions, or any other party, is or will be liable or otherwise responsible for any decision made, any action taken or any action not taken due to the use of any information presented in the prediction tools.